Immunotherapy has been developed for the treatment of metastatic cancers refractory to
conventional therapies. Immunotherapy utilizes immune cells and/or biological response …

Attempts to treat cancer by stimulation of cell-mediated responses in the host (active
immunotherapy) or by adoptive transfer of lymphocytes remain the major areas of research …

Although aggressive utilization of surgery, chemotherapy, and/or radiotherapy have
demonstrated considerable therapeutic efficacy against some tumors, several major forms of …

The use of biologic response modifiers and other immune reagents to stimulate the body's
immune recognition of tumor cells has emerged as a promising new modality of cancer …

The use of immunostimulatory cytokines has become an increasingly promising approach in
cancer immunotherapy. The major goal is the activation of tumour-specific T lymphocytes …

Some of the most dramatic advances in the treatment of cancer have used the immune
system in combination with conventional or transplantation chemotherapy. Adoptive …

David H. Kirn, Editor infiltrates in regressing tumors, assaying cytotoxic T lymphocytes, and
monitoring long-term resistance to tumor growth. The first experimental models and clinical …

IN THE LAST decade biologic therapy has emerged as a mode of treatment capable of
mediating the regression of cancer in some patients. Biologic therapy differs conceptually …

Immunotherapies have been developed that can sigdicantly impact upon advanced disease
in selected cancer patients. Initial studies using high-dose interleukin (1L)-2 …

Immunotherapy, unlike chemotherapy and endocrine therapy which are now established
treatment methods in cancer, is still in the developmental stage, although it has a long …